Explore UAB

Patient Care Connect Program Medical Director Gabrielle Rocque, MDThe Association of Community Cancer Centers recently recognized UAB’s Patient Care Connect Program with its prestigious Innovator Award for its “forward-thinking” approach to improve access and quality of care. Patient Care Connect is a lay navigation program directed by Gabrielle Rocque, MD (Assistant Professor, Hematology and Oncology). The program’s results have been impressive, both in cost savings and patient satisfaction.

IM Residents Karla Williams, M.D. (center) and KeAndrea Titer, M.D. (right) enjoy an evening in the city with friends.The Graduate Medical Education office has released a recruitment video focused on the attractive and enjoyable aspects of resident life in Birmingham. It features residents across all GME programs, including our own KeAndrea Titer, MD (PGY-3) and Karla Williams, MD (CMR). Check out their 2 minutes, 50 seconds of fame, and share the video with potential recruits!

Just in time for the Thanksgiving holiday, grab your tissues and watch four amazing patients express their gratitude for the tremendous care they received at UAB Hospital. These stories both inspire us and encourage us to stay focused on our mission: To improve the health and well-being of society, particularly the citizens of Alabama, by providing innovative health services of exceptional value that are patient- and family-centered, a superior environment for the education of health professionals, and support for research that advances medical science.

A Few Mustached Marauders. L to R: Rehan Sarmad, MD, Daniel LaVie, MD, Will Varnado, MD, and Matt Pierce, MDOne of the senior fellows in the Division of Hematology and Oncology, Daniel LaVie, MD, has organized a team known as the “Mustached Marauders of Malignancy.” Together, they are participating in the movement to “change the face of men’s health” by growing a mustache or beard during "Movember." Each team member started clean-shaven and will grow facial hair throughout the month, so visit their site and vote for your favorite "mo." All proceeds go to the Movember Foundation. 

Professor Steve Rowe, MD, MSPHA two-drug combination therapy for cystic fibrosis improves lung function in patients with certain mutations in the CFTR gene responsible for the disease. In findings published in the New England Journal of Medicine, Steve Rowe, MD, MSPH (Professor, Pulmonary, Allergy, and Critical Care Medicine) and UAB researchers report that the combination of tezacaftor and ivacaftor improved lung function by nearly 7 percent in a subset of patients.